Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$7.17 - $18.55 $7.17 Million - $18.6 Million
1,000,000 New
1,000,000 $16.6 Million
Q3 2021

Nov 15, 2021

SELL
$46.87 - $64.24 $31.6 Million - $43.3 Million
-673,400 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$46.47 - $63.93 $6.58 Million - $9.06 Million
-141,700 Reduced 17.38%
673,400 $41.1 Million
Q1 2021

May 17, 2021

BUY
$55.47 - $72.35 $45.2 Million - $59 Million
815,100 New
815,100 $50.2 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.